Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Epidemiological Study In Hypertensive Patients: Assessment Of Risk Factors Prevalence And Of Patients' Management

This study has been completed.
Sponsor:
Information provided by:
Pfizer
ClinicalTrials.gov Identifier:
NCT00709787
First received: July 1, 2008
Last updated: November 9, 2010
Last verified: March 2009

July 1, 2008
November 9, 2010
June 2008
February 2009   (final data collection date for primary outcome measure)
Description of hypertensive patients in terms of presence of associated cardiovascular (CV) risk factors (number of additional CV risk factors and frequency) [ Designated as safety issue: No ]
Description of hypertensive patients in terms of presence of associated cardiovascular (CV) risk factors (number of additional CV risk factors and frequency) [ Time Frame: Time Frame is N/A ] [ Designated as safety issue: No ]
Complete list of historical versions of study NCT00709787 on ClinicalTrials.gov Archive Site
  • Description of pattern of management of HT and CVD prevention, through lifestyle and use of drug therapies, [ Designated as safety issue: No ]
  • Estimate adherence to treatment using the Morisky Adherence Scale (MAS) [ Designated as safety issue: No ]
  • Estimation of hypertensive patients CV risk stratification based on ESH/ESC Hypertension Guidelines 2007 and to compare it with physicians' estimation of CV risk. [ Designated as safety issue: No ]
  • Description of pattern of management of HT and CVD prevention, through lifestyle and use of drug therapies, [ Time Frame: Time Frame is N/A ] [ Designated as safety issue: No ]
  • Estimate adherence to treatment using the Morisky Adherence Scale (MAS) [ Time Frame: Time Frame is N/A ] [ Designated as safety issue: No ]
  • Estimation of hypertensive patients CV risk stratification based on ESH/ESC Hypertension Guidelines 2007 and to compare it with physicians' estimation of CV risk. [ Time Frame: Time Frame is N/A ] [ Designated as safety issue: No ]
Not Provided
Not Provided
 
Epidemiological Study In Hypertensive Patients: Assessment Of Risk Factors Prevalence And Of Patients' Management
Epidemiological Study In Hypertensive Patients: Assessment Of Risk Factors Prevalence And Of Patients' Management

To assess the pattern of hypertension in the population in terms of presence of additional risk factors (ARF) and cardiovascular risk stratification.

routine physician visits

Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Adult Hypertensive Patients managed in primary care

Hypertension
Other: Usual Care
Normal care for hypertensive patients with risk factors for CHD
Hypertensive Subjects undergoing primary prevention
Intervention: Other: Usual Care
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
899
February 2009
February 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Age 18 to 80 years old
  • Patients with hypertension: newly diagnosed and /or already diagnosed and treated , whether at goal or not for the blood pressure level;
  • Patients with no history of CHD/CVD

Exclusion Criteria:

  • None
Both
18 Years to 80 Years
No
Contact information is only displayed when the study is recruiting subjects
Croatia,   Czech Republic
 
NCT00709787
A3841059
No
Director, Clinical Trial Disclosure Group, Pfizer, Inc.
Pfizer
Not Provided
Study Director: Pfizer CT.gov Call Center Pfizer
Pfizer
March 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP